Teda Pharmaceutical (03880.HK) releases its interim financial results with a net profit attributable to shareholders of 102 million yuan, an increase of 101.71% year-on-year.

Wisdom Channel Finance APP News, TED Pharmaceutical (03880.HK) released its interim results for the six months ending on June 30, 2025, with revenue of 254 million yuan, a year-on-year increase of 28.52%; net profit attributable to shareholders was 102 million yuan, a year-on-year increase of 101.71%; basic earnings per share was 0.82 yuan.